Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), today announced that the company will present insights into its lead isocitrate dehydrogenase (IDH) program at the at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place October 19-23, 2013 in Boston.
Help employers find you! Check out all the jobs and post your resume.
